CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 687283-687510
Annnotations
CORD-19-Sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T20262 | 0-227 | Sentence | denotes | It appears that when Omalizumab is added to the combination H1receptor antagonist, Cetirizine, and nasal corticosteroid, Mometasone furoate, the primary end points (rhinomanometry and symptom scores) are significantly improved. |
Epistemic_Statements
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1137 | 0-227 | Epistemic_statement | denotes | It appears that when Omalizumab is added to the combination H1receptor antagonist, Cetirizine, and nasal corticosteroid, Mometasone furoate, the primary end points (rhinomanometry and symptom scores) are significantly improved. |
CORD-19_Custom_license_subset
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T88 | 0-227 | Sentence | denotes | It appears that when Omalizumab is added to the combination H1receptor antagonist, Cetirizine, and nasal corticosteroid, Mometasone furoate, the primary end points (rhinomanometry and symptom scores) are significantly improved. |